6826 — Shanghai Haohai Biological Technology Co Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMid CapNeutral

Market Cap
HK$6.55bn
Enterprise Value
HK$4.40bn
Revenue
CNY2.65bn

Annual balance sheet for Shanghai Haohai Biological Technology Co, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.

	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	—	—	—	—	—
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	CAS	CAS	CAS	CAS	CAS
Status:	Final	Final	Final	Final	Final
Cash
Short Term Investments
Cash and Short Term Investments	3,231	3,115	2,912	2,548	2,760
Net Total Accounts Receivable
Net Total Receivables	392	345	390	428	398
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	3,945	3,810	3,713	3,532	3,750
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	939	1,037	1,241	1,401	1,548
Net Goodwill
Net Intangible Assets
Long Term Investments
Other Long Term Assets
Total Assets	6,152	6,299	6,950	6,892	7,105
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	360	434	487	511	716
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Minority Interest
Total Other Liabilities
Total Liabilities	697	808	1,237	1,378	1,455
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
Unrealized Gain / Loss
Other Equity
Total Equity	5,455	5,491	5,713	5,515	5,650
Total Liabilities & Shareholders' Equity	6,152	6,299	6,950	6,892	7,105
Total Common Shares Outstanding